drugset / Trial / NCT07451613
Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease
Phase 1/2
Recruiting
21 enrolled
Leslie Thompson
California Institute for Regenerative Medicine (CIRM) · collabUniversity of California, Irvine · collab
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this research study is to determine whether an implantation of hNSC-01 is a safe and tolerable study intervention for Huntington's disease. This study is the first time that hNSC-01 is being tested in people.
Timeline
- Start
- 2026-04-06
- Primary completion
- 2028-06
- Completion
- 2031-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | hNSC-01 | Cell therapy | — | — |